{"transactions":[{"id":747063,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-08T20:07:08.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":false,"shares":21739,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on June 5, 2025 and vested on June 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on June 5, 2025 and vested on June 5, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":21739},"source":{"system":"sec-edgar","filing":"0001193125-26-261715","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261715/ownership.xml","form_type":"4"}},{"id":747062,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-08T20:07:08.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":true,"shares":21739,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":448011,"source":{"system":"sec-edgar","filing":"0001193125-26-261715","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261715/ownership.xml","form_type":"4"}},{"id":757988,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-01T20:03:55.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":10863,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on May 28, 2026 and vest on May 28, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on May 28, 2026 and vest on May 28, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":10863,"derivative":{"underlying":"Ordinary Shares","underlying_shares":10863},"source":{"system":"sec-edgar","filing":"0001193125-26-251384","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526251384/ownership.xml","form_type":"4"}},{"id":1118879,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2025-06-09T20:05:24.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":21739,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on June 5, 2025 and vest on June 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on June 5, 2025 and vest on June 5, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":21739,"derivative":{"underlying":"Ordinary Shares","underlying_shares":21739},"source":{"system":"sec-edgar","filing":"0000950170-25-083706","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025083706/ownership.xml","form_type":"4"}},{"id":1118878,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2025-06-09T20:05:24.000Z","date":"2025-06-06","kind":"exercise","planned":false,"acquired":false,"shares":17158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on June 6, 2024 and vested on June 6, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on June 6, 2024 and vested on June 6, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17158},"source":{"system":"sec-edgar","filing":"0000950170-25-083706","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025083706/ownership.xml","form_type":"4"}},{"id":1118877,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-06-09T20:05:24.000Z","date":"2025-06-06","kind":"exercise","planned":false,"acquired":true,"shares":17158,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":426272,"source":{"system":"sec-edgar","filing":"0000950170-25-083706","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025083706/ownership.xml","form_type":"4"}},{"id":1478051,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2024-06-17T11:14:54.000Z","date":"2024-06-15","kind":"exercise","planned":false,"acquired":false,"shares":37598,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Share Units were granted on June 15, 2023 and vested on June 15, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Share Units were granted on June 15, 2023 and vested on June 15, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":37598},"source":{"system":"sec-edgar","filing":"0000950170-24-074001","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024074001/ownership.xml","form_type":"4"}},{"id":1478050,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-06-17T11:14:54.000Z","date":"2024-06-15","kind":"exercise","planned":false,"acquired":true,"shares":37598,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":409114,"source":{"system":"sec-edgar","filing":"0000950170-24-074001","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024074001/ownership.xml","form_type":"4"}},{"id":1485676,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2024-06-10T11:31:10.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":17158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on June 6, 2024 and vest on June 6, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on June 6, 2024 and vest on June 6, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":17158,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17158},"source":{"system":"sec-edgar","filing":"0000950170-24-071062","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024071062/ownership.xml","form_type":"4"}},{"id":1814232,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2023-08-07T20:02:05.000Z","date":"2023-08-04","kind":"exercise","planned":false,"acquired":false,"shares":28162,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on August 4, 2022 and vested on August 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on August 4, 2022 and vested on August 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":28162},"source":{"system":"sec-edgar","filing":"0001209191-23-044769","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123044769/doc4.xml","form_type":"4"}},{"id":1814231,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-08-07T20:02:05.000Z","date":"2023-08-04","kind":"exercise","planned":false,"acquired":true,"shares":28162,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":371516,"source":{"system":"sec-edgar","filing":"0001209191-23-044769","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123044769/doc4.xml","form_type":"4"}},{"id":1832804,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-07-07T20:16:34.000Z","date":"2023-07-05","kind":"grant","planned":false,"acquired":true,"shares":44983,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":44983,"derivative":{"exercise_price":0.29,"exercise_date":"2024-07-05","expiration_date":"2033-07-04","underlying":"Common Stock","underlying_shares":44983},"source":{"system":"sec-edgar","filing":"0000950170-23-032245","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000095017023032245/ownership.xml","form_type":"4"}},{"id":1850664,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2023-06-20T11:31:06.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":37598,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on June 15, 2023 and vest on June 15, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on June 15, 2023 and vest on June 15, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":37598,"derivative":{"underlying":"Ordinary Shares","underlying_shares":37598},"source":{"system":"sec-edgar","filing":"0001209191-23-038217","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123038217/doc4.xml","form_type":"4"}},{"id":1923589,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-04-07T00:34:44.000Z","date":"2023-04-04","kind":"grant","planned":false,"acquired":true,"shares":155900,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 5, 2020, of which all of the shares subject to such option have vested. Mr. Barer has exercised his right to purchase 50,000 shares subject to the original option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 5, 2020, of which all of the shares subject to such option have vested. Mr. Barer has exercised his right to purchase 50,000 shares subject to the original option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 5, 2020, of which all of the shares subject to such option have vested. Mr. Barer has exercised his right to purchase 50,000 shares subject to the original option."}],"balance_after":155900,"derivative":{"exercise_price":1.64,"expiration_date":"2030-03-04","underlying":"Common Stock","underlying_shares":155900},"source":{"system":"sec-edgar","filing":"0001209191-23-023681","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919123023681/doc4.xml","form_type":"4"}},{"id":1923588,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-04-07T00:34:44.000Z","date":"2023-04-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":155900,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 5, 2020, of which all of the shares subject to such option have vested. Mr. Barer has exercised his right to purchase 50,000 shares subject to the original option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 5, 2020, of which all of the shares subject to such option have vested. Mr. Barer has exercised his right to purchase 50,000 shares subject to the original option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 5, 2020, of which all of the shares subject to such option have vested. Mr. Barer has exercised his right to purchase 50,000 shares subject to the original option."}],"balance_after":0,"derivative":{"exercise_price":5.17,"expiration_date":"2030-03-04","underlying":"Common Stock","underlying_shares":155900},"source":{"system":"sec-edgar","filing":"0001209191-23-023681","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919123023681/doc4.xml","form_type":"4"}},{"id":1923587,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-04-07T00:34:44.000Z","date":"2023-04-04","kind":"grant","planned":false,"acquired":true,"shares":19113,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 11, 2021, of which all of the shares subject to such option have vested."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 11, 2021, of which all of the shares subject to such option have vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 11, 2021, of which all of the shares subject to such option have vested."}],"balance_after":19113,"derivative":{"exercise_price":1.64,"expiration_date":"2031-02-10","underlying":"Common Stock","underlying_shares":19113},"source":{"system":"sec-edgar","filing":"0001209191-23-023681","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919123023681/doc4.xml","form_type":"4"}},{"id":1923586,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-04-07T00:34:44.000Z","date":"2023-04-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":19113,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 11, 2021, of which all of the shares subject to such option have vested."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 11, 2021, of which all of the shares subject to such option have vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 11, 2021, of which all of the shares subject to such option have vested."}],"balance_after":0,"derivative":{"exercise_price":17,"expiration_date":"2031-02-10","underlying":"Common Stock","underlying_shares":19113},"source":{"system":"sec-edgar","filing":"0001209191-23-023681","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919123023681/doc4.xml","form_type":"4"}},{"id":1923585,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-04-07T00:34:44.000Z","date":"2023-04-04","kind":"grant","planned":false,"acquired":true,"shares":61678,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on June 13, 2022, of which all of the shares subject to such option will vest on June 13, 2023, subject to Mr. Barer's continued service on such vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on June 13, 2022, of which all of the shares subject to such option will vest on June 13, 2023, subject to Mr. Barer's continued service on such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on June 13, 2022, of which all of the shares subject to such option will vest on June 13, 2023, subject to Mr. Barer's continued service on such vesting date."}],"balance_after":61678,"derivative":{"exercise_price":1.64,"expiration_date":"2032-06-12","underlying":"Common Stock","underlying_shares":61678},"source":{"system":"sec-edgar","filing":"0001209191-23-023681","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919123023681/doc4.xml","form_type":"4"}},{"id":1923584,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-04-07T00:34:44.000Z","date":"2023-04-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":61678,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on June 13, 2022, of which all of the shares subject to such option will vest on June 13, 2023, subject to Mr. Barer's continued service on such vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on June 13, 2022, of which all of the shares subject to such option will vest on June 13, 2023, subject to Mr. Barer's continued service on such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on June 13, 2022, of which all of the shares subject to such option will vest on June 13, 2023, subject to Mr. Barer's continued service on such vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.82,"expiration_date":"2032-06-12","underlying":"Common Stock","underlying_shares":61678},"source":{"system":"sec-edgar","filing":"0001209191-23-023681","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919123023681/doc4.xml","form_type":"4"}},{"id":1933833,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-31T20:56:29.000Z","date":"2023-03-30","kind":"purchase","planned":false,"acquired":true,"shares":400000,"price":0.4103,"value":164120.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.4000 to $0.4200, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Excludes 175,012 shares of common stock underlying options that are currently exercisable."}],"balance_after":2217814,"source":{"system":"sec-edgar","filing":"0001209191-23-021889","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919123021889/doc4.xml","form_type":"4"}},{"id":2111860,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-18T01:40:11.000Z","date":"2022-11-16","kind":"purchase","acquired":true,"shares":125000,"price":0.4824,"value":60300.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.4557 to $0.4900, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Excludes 175,012 shares of common stock underlying options that are currently exercisable."}],"balance_after":1742814,"source":{"system":"sec-edgar","filing":"0001209191-22-057746","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919122057746/doc4.xml","form_type":"4"}},{"id":2111859,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-18T01:40:11.000Z","date":"2022-11-17","kind":"purchase","acquired":true,"shares":75000,"price":0.4789,"value":35917.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.4754 to $0.4890, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Excludes 175,012 shares of common stock underlying options that are currently exercisable."}],"balance_after":1817814,"source":{"system":"sec-edgar","filing":"0001209191-22-057746","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919122057746/doc4.xml","form_type":"4"}},{"id":2192408,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2022-08-08T11:10:25.000Z","date":"2022-08-04","kind":"grant","acquired":true,"shares":28162,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on August 4, 2022 and vest on August 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on August 4, 2022 and vest on August 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":28162,"derivative":{"underlying":"Ordinary Shares","underlying_shares":28162},"source":{"system":"sec-edgar","filing":"0001209191-22-044689","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122044689/doc4.xml","form_type":"4"}},{"id":2230747,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2022-06-16T11:32:38.000Z","date":"2022-06-14","kind":"exercise","acquired":false,"shares":25791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on June 14, 2021 and vested on June 14, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on June 14, 2021 and vested on June 14, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":25791},"source":{"system":"sec-edgar","filing":"0001209191-22-037243","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122037243/doc4.xml","form_type":"4"}},{"id":2230746,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-06-16T11:32:38.000Z","date":"2022-06-14","kind":"exercise","acquired":true,"shares":25791,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":343354,"source":{"system":"sec-edgar","filing":"0001209191-22-037243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122037243/doc4.xml","form_type":"4"}},{"id":2231295,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-15T20:57:59.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":61678,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":61678,"derivative":{"exercise_price":1.82,"exercise_date":"2023-06-13","expiration_date":"2032-06-12","underlying":"Common Stock","underlying_shares":61678},"source":{"system":"sec-edgar","filing":"0001209191-22-037010","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919122037010/doc4.xml","form_type":"4"}},{"id":2247198,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-02T23:41:17.000Z","date":"2022-05-31","kind":"purchase","acquired":true,"shares":39280,"price":2.1867,"value":85893.576,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.95 to $2.46, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Excludes 175,012 shares of common stock underlying options that are currently exercisable."}],"balance_after":1557094,"source":{"system":"sec-edgar","filing":"0001209191-22-033727","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919122033727/doc4.xml","form_type":"4"}},{"id":2247197,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-02T23:41:17.000Z","date":"2022-06-01","kind":"purchase","acquired":true,"shares":40000,"price":2.354,"value":94160.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.23 to $2.59, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Excludes 175,012 shares of common stock underlying options that are currently exercisable."}],"balance_after":1597094,"source":{"system":"sec-edgar","filing":"0001209191-22-033727","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919122033727/doc4.xml","form_type":"4"}},{"id":2247196,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-02T23:41:17.000Z","date":"2022-06-02","kind":"purchase","acquired":true,"shares":20720,"price":2.2249,"value":46099.928,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.09 to $2.35, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Excludes 175,012 shares of common stock underlying options that are currently exercisable."}],"balance_after":1617814,"source":{"system":"sec-edgar","filing":"0001209191-22-033727","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919122033727/doc4.xml","form_type":"4"}},{"id":2265600,"issuer":{"id":116797,"kind":"organization","name":"CONTRAFECT Corp","symbol":"CFRX"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2022-05-18T17:59:08.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":42000,"price":3.35,"value":140700.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant award made under the ContraFect Corporation 2014 Omnibus Incentive Plan.  Grant vests over one year, 25% at the end of each quarter following the vesting commencement date."}],"balance_after":42000,"derivative":{"exercise_price":3.35,"expiration_date":"2032-05-17","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001209191-22-030193","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478069/000120919122030193/doc4.xml","form_type":"4"}},{"id":2318709,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-24T20:15:25.000Z","date":"2022-03-23","kind":"purchase","acquired":true,"shares":10000,"price":2.6653,"value":26653.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.43 to $2.785, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Excludes 175,012 shares of common stock underlying options that are currently exercisable."}],"balance_after":1517814,"source":{"system":"sec-edgar","filing":"0001209191-22-020914","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919122020914/doc4.xml","form_type":"4"}},{"id":2319914,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-23T20:15:27.000Z","date":"2022-03-22","kind":"purchase","acquired":true,"shares":30000,"price":2.41,"value":72300.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.13 to $2.69, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Excludes 175,012 shares of common stock underlying options that are currently exercisable."}],"balance_after":1507814,"source":{"system":"sec-edgar","filing":"0001209191-22-020766","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919122020766/doc4.xml","form_type":"4"}},{"id":2321098,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-22T20:15:15.000Z","date":"2022-03-21","kind":"purchase","acquired":true,"shares":30000,"price":2.136,"value":64080.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.05 to $2.235, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Excludes 175,012 shares of common stock underlying options that are currently exercisable."}],"balance_after":1477814,"source":{"system":"sec-edgar","filing":"0001209191-22-020522","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919122020522/doc4.xml","form_type":"4"}},{"id":2322949,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-21T20:10:11.000Z","date":"2022-03-18","kind":"purchase","acquired":true,"shares":30000,"price":2.107,"value":63210.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.96 to $2.28, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Excludes 175,012 shares of common stock underlying options that are currently exercisable."}],"balance_after":1447814,"source":{"system":"sec-edgar","filing":"0001209191-22-020256","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919122020256/doc4.xml","form_type":"4"}},{"id":2460746,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-12-22T13:00:09.000Z","date":"2021-12-21","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":155900,"derivative":{"exercise_price":5.17,"exercise_date":"2021-02-11","expiration_date":"2030-03-04","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-21-070879","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919121070879/doc4.xml","form_type":"4"}},{"id":2460745,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-22T13:00:09.000Z","date":"2021-12-21","kind":"exercise","acquired":true,"shares":50000,"price":5.17,"value":258500.0,"ownership":{"direct":true},"balance_after":1417814,"source":{"system":"sec-edgar","filing":"0001209191-21-070879","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919121070879/doc4.xml","form_type":"4"}},{"id":2663257,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T20:33:32.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock option will be fully vested and exercisable on June 15, 2022, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":3.56,"exercise_date":"2022-06-15","expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001192482-21-000521","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000119248221000521/edgar.xml","form_type":"4"}},{"id":2667198,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2021-06-16T12:10:26.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":25791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on June 14, 2021 and vest on June 14, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on June 14, 2021 and vest on June 14, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":25791,"derivative":{"underlying":"Ordinary Shares","underlying_shares":25791},"source":{"system":"sec-edgar","filing":"0001209191-21-040805","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121040805/doc4.xml","form_type":"4"}},{"id":2674684,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2021-06-10T11:39:01.000Z","date":"2021-06-09","kind":"exercise","acquired":false,"shares":22565,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on June 9, 2020 and vested on June 9, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on June 9, 2020 and vested on June 9, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":22565},"source":{"system":"sec-edgar","filing":"0001209191-21-039367","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121039367/doc4.xml","form_type":"4"}},{"id":2674683,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-06-10T11:39:01.000Z","date":"2021-06-09","kind":"exercise","acquired":true,"shares":22565,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":317563,"source":{"system":"sec-edgar","filing":"0001209191-21-039367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121039367/doc4.xml","form_type":"4"}},{"id":2678392,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2021-06-08T11:23:23.000Z","date":"2021-06-05","kind":"exercise","acquired":false,"shares":17565,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on June 5, 2018 and vested on June 5, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on June 5, 2018 and vested on June 5, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17565},"source":{"system":"sec-edgar","filing":"0001209191-21-038811","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121038811/doc4.xml","form_type":"4"}},{"id":2678391,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-06-08T11:23:23.000Z","date":"2021-06-05","kind":"exercise","acquired":true,"shares":17565,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":294998,"source":{"system":"sec-edgar","filing":"0001209191-21-038811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121038811/doc4.xml","form_type":"4"}},{"id":2703092,"issuer":{"id":116797,"kind":"organization","name":"CONTRAFECT Corp","symbol":"CFRX"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2021-05-20T19:43:29.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant award made under the ContraFect Corporation Omnibus Incentive Plan.  Grant vests over one year, 25% at the end of each quarter following the vesting commencement date."}],"balance_after":25000,"derivative":{"exercise_price":3.86,"expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-21-034647","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478069/000120919121034647/doc4.xml","form_type":"4"}},{"id":2845802,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-02-19T21:20:36.000Z","date":"2021-02-17","kind":"exercise","acquired":false,"shares":217570,"ownership":{"direct":false,"nature":"Held by Joshua Barer"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of preferred stock automatically converted into common stock immediately upon completion of the Issuer's initial public offering on a 1-for-1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of preferred stock automatically converted into common stock immediately upon completion of the Issuer's initial public offering on a 1-for-1 basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares of preferred stock were convertible into the Issuer's common stock in accordance with the Issuer's Restated Certificate of Incorporation, as amended, immediately upon completion of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Not applicable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Mr. Barer is the father of Joshua Barer. Mr. Sol Barer disclaims beneficial ownership of the securities held by Joshua Barer except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":217570},"source":{"system":"sec-edgar","filing":"0001209191-21-012354","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919121012354/doc4.xml","form_type":"4"}},{"id":2845801,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2021-02-19T21:20:36.000Z","date":"2021-02-17","kind":"exercise","acquired":false,"reported_value":2875458,"ownership":{"direct":false,"nature":"Held by B&S NexImmune Holdco LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On February 17, 2021 (the \"Closing\"), the convertible promissory notes (the \"Notes\") became automatically convertible into shares of the Issuer's common stock. At the Closing, the principal amount of the Notes, plus accrued but unpaid interest thereon through February 17, 2021, converted into shares of the Issuer's common stock by dividing the principal and accrued but unpaid interest under such Note by the price per share obtained by dividing $125,000,000 by the Company's fully-diluted capitalization immediately prior to the IPO, assuming exercise or conversion of all convertible securities of the Company but excluding any shares issuable upon conversion of the Notes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 17, 2021 (the \"Closing\"), the convertible promissory notes (the \"Notes\") became automatically convertible into shares of the Issuer's common stock. At the Closing, the principal amount of the Notes, plus accrued but unpaid interest thereon through February 17, 2021, converted into shares of the Issuer's common stock by dividing the principal and accrued but unpaid interest under such Note by the price per share obtained by dividing $125,000,000 by the Company's fully-diluted capitalization immediately prior to the IPO, assuming exercise or conversion of all convertible securities of the Company but excluding any shares issuable upon conversion of the Notes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 17, 2021 (the \"Closing\"), the convertible promissory notes (the \"Notes\") became automatically convertible into shares of the Issuer's common stock. At the Closing, the principal amount of the Notes, plus accrued but unpaid interest thereon through February 17, 2021, converted into shares of the Issuer's common stock by dividing the principal and accrued but unpaid interest under such Note by the price per share obtained by dividing $125,000,000 by the Company's fully-diluted capitalization immediately prior to the IPO, assuming exercise or conversion of all convertible securities of the Company but excluding any shares issuable upon conversion of the Notes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Not applicable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Barer is the father of Joshua Barer, who is the sole manager of B&S NexImmune Holdco LLC and has sole voting and dispositive control over the shares held by B&S NexImmune Holdco LLC. Mr. Sol Barer is also a member of Barer & Son Capital, LLC, which is a member of B&S NexImmune Holdco LLC, but he does not have voting or dispositive control over the shares held by B&S NexImmune Holdco LLC. Mr. Sol Barer disclaims beneficial ownership of the securities held by B&S NexImmune Holdco LLC except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":337365},"source":{"system":"sec-edgar","filing":"0001209191-21-012354","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919121012354/doc4.xml","form_type":"4"}},{"id":2845800,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A3 Preferred Stock","published_at":"2021-02-19T21:20:36.000Z","date":"2021-02-17","kind":"exercise","acquired":false,"shares":82204,"ownership":{"direct":false,"nature":"Held by B&S NexImmune Holdco LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of preferred stock automatically converted into common stock immediately upon completion of the Issuer's initial public offering on a 1-for-1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of preferred stock automatically converted into common stock immediately upon completion of the Issuer's initial public offering on a 1-for-1 basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares of preferred stock were convertible into the Issuer's common stock in accordance with the Issuer's Restated Certificate of Incorporation, as amended, immediately upon completion of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Not applicable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Barer is the father of Joshua Barer, who is the sole manager of B&S NexImmune Holdco LLC and has sole voting and dispositive control over the shares held by B&S NexImmune Holdco LLC. Mr. Sol Barer is also a member of Barer & Son Capital, LLC, which is a member of B&S NexImmune Holdco LLC, but he does not have voting or dispositive control over the shares held by B&S NexImmune Holdco LLC. Mr. Sol Barer disclaims beneficial ownership of the securities held by B&S NexImmune Holdco LLC except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":82204},"source":{"system":"sec-edgar","filing":"0001209191-21-012354","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919121012354/doc4.xml","form_type":"4"}},{"id":2845799,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A2 Preferred Stock","published_at":"2021-02-19T21:20:36.000Z","date":"2021-02-17","kind":"exercise","acquired":false,"shares":164408,"ownership":{"direct":false,"nature":"Held B&S NexImmune Holdco LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of preferred stock automatically converted into common stock immediately upon completion of the Issuer's initial public offering on a 1-for-1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of preferred stock automatically converted into common stock immediately upon completion of the Issuer's initial public offering on a 1-for-1 basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares of preferred stock were convertible into the Issuer's common stock in accordance with the Issuer's Restated Certificate of Incorporation, as amended, immediately upon completion of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Not applicable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Barer is the father of Joshua Barer, who is the sole manager of B&S NexImmune Holdco LLC and has sole voting and dispositive control over the shares held by B&S NexImmune Holdco LLC. Mr. Sol Barer is also a member of Barer & Son Capital, LLC, which is a member of B&S NexImmune Holdco LLC, but he does not have voting or dispositive control over the shares held by B&S NexImmune Holdco LLC. Mr. Sol Barer disclaims beneficial ownership of the securities held by B&S NexImmune Holdco LLC except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":164408},"source":{"system":"sec-edgar","filing":"0001209191-21-012354","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919121012354/doc4.xml","form_type":"4"}},{"id":2845798,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-02-19T21:20:36.000Z","date":"2021-02-17","kind":"exercise","acquired":false,"shares":894036,"ownership":{"direct":false,"nature":"Held by B&S NexImmune Holdco LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of preferred stock automatically converted into common stock immediately upon completion of the Issuer's initial public offering on a 1-for-1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of preferred stock automatically converted into common stock immediately upon completion of the Issuer's initial public offering on a 1-for-1 basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares of preferred stock were convertible into the Issuer's common stock in accordance with the Issuer's Restated Certificate of Incorporation, as amended, immediately upon completion of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Not applicable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Barer is the father of Joshua Barer, who is the sole manager of B&S NexImmune Holdco LLC and has sole voting and dispositive control over the shares held by B&S NexImmune Holdco LLC. Mr. Sol Barer is also a member of Barer & Son Capital, LLC, which is a member of B&S NexImmune Holdco LLC, but he does not have voting or dispositive control over the shares held by B&S NexImmune Holdco LLC. Mr. Sol Barer disclaims beneficial ownership of the securities held by B&S NexImmune Holdco LLC except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":894036},"source":{"system":"sec-edgar","filing":"0001209191-21-012354","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919121012354/doc4.xml","form_type":"4"}},{"id":2845797,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-02-19T21:20:36.000Z","date":"2021-02-17","kind":"exercise","acquired":false,"shares":800182,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of preferred stock automatically converted into common stock immediately upon completion of the Issuer's initial public offering on a 1-for-1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of preferred stock automatically converted into common stock immediately upon completion of the Issuer's initial public offering on a 1-for-1 basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares of preferred stock were convertible into the Issuer's common stock in accordance with the Issuer's Restated Certificate of Incorporation, as amended, immediately upon completion of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Not applicable."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":800182},"source":{"system":"sec-edgar","filing":"0001209191-21-012354","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919121012354/doc4.xml","form_type":"4"}},{"id":2845796,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T21:20:36.000Z","date":"2021-02-17","kind":"exercise","acquired":true,"shares":217570,"ownership":{"direct":false,"nature":"Held by Joshua Barer"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of preferred stock automatically converted into common stock immediately upon completion of the Issuer's initial public offering on a 1-for-1 basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Mr. Barer is the father of Joshua Barer. Mr. Sol Barer disclaims beneficial ownership of the securities held by Joshua Barer except to the extent of his pecuniary interest therein."}],"balance_after":346577,"source":{"system":"sec-edgar","filing":"0001209191-21-012354","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919121012354/doc4.xml","form_type":"4"}},{"id":2845795,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T21:20:36.000Z","date":"2021-02-17","kind":"purchase","acquired":true,"shares":60000,"price":17,"value":1020000.0,"ownership":{"direct":false,"nature":"Held by B&S NexImmune Holdco LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Reflects shares purchased in the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Barer is the father of Joshua Barer, who is the sole manager of B&S NexImmune Holdco LLC and has sole voting and dispositive control over the shares held by B&S NexImmune Holdco LLC. Mr. Sol Barer is also a member of Barer & Son Capital, LLC, which is a member of B&S NexImmune Holdco LLC, but he does not have voting or dispositive control over the shares held by B&S NexImmune Holdco LLC. Mr. Sol Barer disclaims beneficial ownership of the securities held by B&S NexImmune Holdco LLC except to the extent of his pecuniary interest therein."}],"balance_after":1538013,"source":{"system":"sec-edgar","filing":"0001209191-21-012354","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919121012354/doc4.xml","form_type":"4"}},{"id":2845794,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T21:20:36.000Z","date":"2021-02-17","kind":"exercise","acquired":true,"shares":337365,"ownership":{"direct":false,"nature":"Held by B&S NexImmune Holdco LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 17, 2021 (the \"Closing\"), the convertible promissory notes (the \"Notes\") became automatically convertible into shares of the Issuer's common stock. At the Closing, the principal amount of the Notes, plus accrued but unpaid interest thereon through February 17, 2021, converted into shares of the Issuer's common stock by dividing the principal and accrued but unpaid interest under such Note by the price per share obtained by dividing $125,000,000 by the Company's fully-diluted capitalization immediately prior to the IPO, assuming exercise or conversion of all convertible securities of the Company but excluding any shares issuable upon conversion of the Notes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Barer is the father of Joshua Barer, who is the sole manager of B&S NexImmune Holdco LLC and has sole voting and dispositive control over the shares held by B&S NexImmune Holdco LLC. Mr. Sol Barer is also a member of Barer & Son Capital, LLC, which is a member of B&S NexImmune Holdco LLC, but he does not have voting or dispositive control over the shares held by B&S NexImmune Holdco LLC. Mr. Sol Barer disclaims beneficial ownership of the securities held by B&S NexImmune Holdco LLC except to the extent of his pecuniary interest therein."}],"balance_after":1478013,"source":{"system":"sec-edgar","filing":"0001209191-21-012354","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919121012354/doc4.xml","form_type":"4"}},{"id":2845793,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T21:20:36.000Z","date":"2021-02-17","kind":"exercise","acquired":true,"shares":82204,"ownership":{"direct":false,"nature":"Held by B&S NexImmune Holdco LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of preferred stock automatically converted into common stock immediately upon completion of the Issuer's initial public offering on a 1-for-1 basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Barer is the father of Joshua Barer, who is the sole manager of B&S NexImmune Holdco LLC and has sole voting and dispositive control over the shares held by B&S NexImmune Holdco LLC. Mr. Sol Barer is also a member of Barer & Son Capital, LLC, which is a member of B&S NexImmune Holdco LLC, but he does not have voting or dispositive control over the shares held by B&S NexImmune Holdco LLC. Mr. Sol Barer disclaims beneficial ownership of the securities held by B&S NexImmune Holdco LLC except to the extent of his pecuniary interest therein."}],"balance_after":1140648,"source":{"system":"sec-edgar","filing":"0001209191-21-012354","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919121012354/doc4.xml","form_type":"4"}},{"id":2845792,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T21:20:36.000Z","date":"2021-02-17","kind":"exercise","acquired":true,"shares":164408,"ownership":{"direct":false,"nature":"Held by B&S NexImmune Holdco LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of preferred stock automatically converted into common stock immediately upon completion of the Issuer's initial public offering on a 1-for-1 basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Barer is the father of Joshua Barer, who is the sole manager of B&S NexImmune Holdco LLC and has sole voting and dispositive control over the shares held by B&S NexImmune Holdco LLC. Mr. Sol Barer is also a member of Barer & Son Capital, LLC, which is a member of B&S NexImmune Holdco LLC, but he does not have voting or dispositive control over the shares held by B&S NexImmune Holdco LLC. Mr. Sol Barer disclaims beneficial ownership of the securities held by B&S NexImmune Holdco LLC except to the extent of his pecuniary interest therein."}],"balance_after":1058444,"source":{"system":"sec-edgar","filing":"0001209191-21-012354","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919121012354/doc4.xml","form_type":"4"}},{"id":2845791,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T21:20:36.000Z","date":"2021-02-17","kind":"exercise","acquired":true,"shares":894036,"ownership":{"direct":false,"nature":"Held by B&S NexImmune Holdco LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of preferred stock automatically converted into common stock immediately upon completion of the Issuer's initial public offering on a 1-for-1 basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Barer is the father of Joshua Barer, who is the sole manager of B&S NexImmune Holdco LLC and has sole voting and dispositive control over the shares held by B&S NexImmune Holdco LLC. Mr. Sol Barer is also a member of Barer & Son Capital, LLC, which is a member of B&S NexImmune Holdco LLC, but he does not have voting or dispositive control over the shares held by B&S NexImmune Holdco LLC. Mr. Sol Barer disclaims beneficial ownership of the securities held by B&S NexImmune Holdco LLC except to the extent of his pecuniary interest therein."}],"balance_after":894036,"source":{"system":"sec-edgar","filing":"0001209191-21-012354","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919121012354/doc4.xml","form_type":"4"}},{"id":2845790,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T21:20:36.000Z","date":"2021-02-17","kind":"exercise","acquired":true,"shares":800182,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of preferred stock automatically converted into common stock immediately upon completion of the Issuer's initial public offering on a 1-for-1 basis."}],"balance_after":1367814,"source":{"system":"sec-edgar","filing":"0001209191-21-012354","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919121012354/doc4.xml","form_type":"4"}},{"id":2858665,"issuer":{"id":89921,"kind":"organization","name":"NexImmune, Inc.","symbol":"NEXI"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-02-16T19:25:57.000Z","date":"2021-02-11","kind":"grant","acquired":true,"shares":19113,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options will vest and become exercisable at the first anniversary of the vesting commencement date (2/11/21)."}],"balance_after":225013,"derivative":{"exercise_price":17,"expiration_date":"2025-02-11","underlying":"Common Stock","underlying_shares":19113},"source":{"system":"sec-edgar","filing":"0001209191-21-010657","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000120919121010657/doc4.xml","form_type":"4"}},{"id":3059340,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2020-08-13T20:06:25.000Z","date":"2020-08-11","kind":"exercise","acquired":false,"shares":23133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on August 11, 2017 and vested on August 11, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on August 11, 2017 and vested on August 11, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":23133},"source":{"system":"sec-edgar","filing":"0001209191-20-046579","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120046579/doc4.xml","form_type":"4"}},{"id":3059339,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-08-13T20:06:25.000Z","date":"2020-08-11","kind":"exercise","acquired":true,"shares":23133,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":277433,"source":{"system":"sec-edgar","filing":"0001209191-20-046579","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120046579/doc4.xml","form_type":"4"}},{"id":3104135,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-19T20:13:59.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Subject to the Reporting Person's continued service on such vesting date, the stock option will vest as follows: 1) 1/2 of the shares will vest on June 18, 2020, with an exercise price of $2.51; 2) the next 1/4 of the shares will vest upon the Issuer's stock price reaching a 50% premium to the Issuer's stock price on June 18, 2020, and will have the exercise price of the Issuer's stock price at that time; and 3) the final 1/4 of the shares will vest upon the Issuer's stock price reaching a 75% premium to the Issuer's stock price on June 18, 2020, and will have an exercise price of the Issuer's stock price at that time."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continued service on such vesting date, the stock option will vest as follows: 1) 1/2 of the shares will vest on June 18, 2020, with an exercise price of $2.51; 2) the next 1/4 of the shares will vest upon the Issuer's stock price reaching a 50% premium to the Issuer's stock price on June 18, 2020, and will have the exercise price of the Issuer's stock price at that time; and 3) the final 1/4 of the shares will vest upon the Issuer's stock price reaching a 75% premium to the Issuer's stock price on June 18, 2020, and will have an exercise price of the Issuer's stock price at that time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person's continued service on such vesting date, the stock option will vest as follows: 1) 1/2 of the shares will vest on June 18, 2020, with an exercise price of $2.51; 2) the next 1/4 of the shares will vest upon the Issuer's stock price reaching a 50% premium to the Issuer's stock price on June 18, 2020, and will have the exercise price of the Issuer's stock price at that time; and 3) the final 1/4 of the shares will vest upon the Issuer's stock price reaching a 75% premium to the Issuer's stock price on June 18, 2020, and will have an exercise price of the Issuer's stock price at that time."}],"balance_after":1000000,"derivative":{"exercise_date":"2020-06-18","expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001192482-20-000546","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000119248220000546/edgar.xml","form_type":"4"}},{"id":3104134,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-19T20:13:59.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock option will be fully vested and exercisable on June 18, 2021, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":2.51,"exercise_date":"2021-06-18","expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001192482-20-000546","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000119248220000546/edgar.xml","form_type":"4"}},{"id":3111161,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2020-06-15T11:31:12.000Z","date":"2020-06-11","kind":"exercise","acquired":false,"shares":31388,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on June 11, 2019 and vested on June 11, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on June 11, 2019 and vested on June 11, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":31388},"source":{"system":"sec-edgar","filing":"0001209191-20-036494","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120036494/doc4.xml","form_type":"4"}},{"id":3111160,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-06-15T11:31:12.000Z","date":"2020-06-11","kind":"exercise","acquired":true,"shares":31388,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":254300,"source":{"system":"sec-edgar","filing":"0001209191-20-036494","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120036494/doc4.xml","form_type":"4"}},{"id":3114014,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2020-06-11T11:09:20.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":22565,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on June 9, 2020 and vest on June 9, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on June 9, 2020 and vest on June 9, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":22565,"derivative":{"underlying":"Ordinary Shares","underlying_shares":22565},"source":{"system":"sec-edgar","filing":"0001209191-20-035779","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120035779/doc4.xml","form_type":"4"}},{"id":3268513,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2020-02-18T12:19:30.000Z","date":"2020-02-14","kind":"exercise","acquired":false,"shares":2470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on February 14, 2017 and vested on February 14, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on February 14, 2017 and vested on February 14, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2470},"source":{"system":"sec-edgar","filing":"0001209191-20-009876","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120009876/doc4.xml","form_type":"4"}},{"id":3268512,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-02-18T12:19:30.000Z","date":"2020-02-14","kind":"exercise","acquired":true,"shares":2470,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":222912,"source":{"system":"sec-edgar","filing":"0001209191-20-009876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120009876/doc4.xml","form_type":"4"}},{"id":3288405,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-05T21:38:11.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest over over three years, with one-third of such option vesting on each of the first, second and third anniversaries of the date of grant."}],"balance_after":500000,"derivative":{"exercise_price":3.98,"expiration_date":"2030-02-03","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001104659-20-011266","document":"tm206826d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247015/000110465920011266/tm206826d1_4.xml","form_type":"4"}},{"id":3289190,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2020-02-05T16:25:30.000Z","date":"2020-02-03","kind":"disposition_to_issuer","acquired":false,"shares":74912,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This warrant, which was issued pursuant to a Securities Purchase Agreement dated August 9, 2017, was subsequently amended by the Amendment Agreement of Warrants to Purchase Common Stock dated December\n5, 2019, whereby immediately prior to the Merger the warrants were automatically exercised in a cashless exercise. Given the exercise price of the outstanding warrants, the cashless exercise resulted in no shares of common\nstock being issued and the warrant was rendered null and void."}],"balance_after":0,"derivative":{"exercise_price":2.84,"expiration_date":"2022-10-17","underlying":"Common Stock","underlying_shares":74912},"source":{"system":"sec-edgar","filing":"0001192482-20-000127","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000119248220000127/edgar.xml","form_type":"4"}},{"id":3289189,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2020-02-05T16:25:30.000Z","date":"2020-02-03","kind":"disposition_to_issuer","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option, which became exercisable on April 17, 2019, was automatically cancelled and ceased to exist without any consideration or payment pursuant to the Merger."}],"balance_after":0,"derivative":{"exercise_price":1.55,"expiration_date":"2028-04-17","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001192482-20-000127","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000119248220000127/edgar.xml","form_type":"4"}},{"id":3289188,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2020-02-05T16:25:30.000Z","date":"2020-02-03","kind":"disposition_to_issuer","acquired":false,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option, which became exercisable on June 22, 2018, was automatically cancelled and ceased to exist without any consideration or payment pursuant to the Merger."}],"balance_after":0,"derivative":{"exercise_price":1.32,"expiration_date":"2027-06-22","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001192482-20-000127","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000119248220000127/edgar.xml","form_type":"4"}},{"id":3289187,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2020-02-05T16:25:30.000Z","date":"2020-02-03","kind":"disposition_to_issuer","acquired":false,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option, which became exercisable on April 15, 2017, was automatically cancelled and ceased to exist without any consideration or payment pursuant to the Merger."}],"balance_after":0,"derivative":{"exercise_price":4.83,"expiration_date":"2026-04-15","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001192482-20-000127","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000119248220000127/edgar.xml","form_type":"4"}},{"id":3289186,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2020-02-05T16:25:30.000Z","date":"2020-02-03","kind":"disposition_to_issuer","acquired":false,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option, which became exercisable on February 18, 2016, was automatically cancelled and ceased to exist without any consideration or payment pursuant to the Merger."}],"balance_after":0,"derivative":{"exercise_price":7.01,"expiration_date":"2025-02-18","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001192482-20-000127","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000119248220000127/edgar.xml","form_type":"4"}},{"id":3289185,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2020-02-05T16:25:30.000Z","date":"2020-02-03","kind":"disposition_to_issuer","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, which became exercisable on January 2, 2015, was automatically cancelled and ceased to exist without any consideration or payment pursuant to the Merger."}],"balance_after":0,"derivative":{"exercise_price":6.5,"expiration_date":"2024-01-02","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001192482-20-000127","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000119248220000127/edgar.xml","form_type":"4"}},{"id":3289184,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2020-02-05T16:25:30.000Z","date":"2020-02-03","kind":"disposition_to_issuer","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, which became exercisable on January 2, 2014, was automatically cancelled and ceased to exist without any consideration or payment pursuant to the Merger."}],"balance_after":0,"derivative":{"exercise_price":7.25,"expiration_date":"2023-01-02","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001192482-20-000127","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000119248220000127/edgar.xml","form_type":"4"}},{"id":3289183,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2020-02-05T16:25:30.000Z","date":"2020-02-03","kind":"disposition_to_issuer","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the Sol J. Barer 2013 Grantor Retained Annuity Trust III"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, which became exercisable on September 13, 2014, was automatically cancelled and ceased to exist without any consideration or payment pursuant to the previously announced Agreement and Plan of Merger and Reorganization by and among Cerecor Inc. (\"Cerecor\"), Genie Merger Sub, Inc., Second Genie Merger Sub,\nLLC and issuer (the \"Merger\")."}],"balance_after":0,"derivative":{"exercise_price":5.22,"expiration_date":"2023-09-13","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001192482-20-000127","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000119248220000127/edgar.xml","form_type":"4"}},{"id":3289182,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2020-02-05T16:25:30.000Z","date":"2020-02-03","kind":"disposition_to_issuer","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, which became exercisable on September 13, 2014, was automatically cancelled and ceased to exist without any consideration or payment pursuant to the previously announced Agreement and Plan of Merger and Reorganization by and among Cerecor Inc. (\"Cerecor\"), Genie Merger Sub, Inc., Second Genie Merger Sub,\nLLC and issuer (the \"Merger\")."}],"balance_after":0,"derivative":{"exercise_price":5.22,"expiration_date":"2023-09-13","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001192482-20-000127","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000119248220000127/edgar.xml","form_type":"4"}},{"id":3348347,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-09T21:10:48.000Z","date":"2019-12-05","kind":"sale","acquired":false,"shares":4098752,"price":0.134,"value":549232.768,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001192482-19-000509","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000119248219000509/edgar.xml","form_type":"4"}},{"id":3348346,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-09T21:10:48.000Z","date":"2019-12-05","kind":"other","acquired":true,"shares":2551020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Pro rata distribution from Barer & Son Capital LLC, of which the Reporting Person is a member."}],"balance_after":4098752,"source":{"system":"sec-edgar","filing":"0001192482-19-000509","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000119248219000509/edgar.xml","form_type":"4"}},{"id":3348345,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-09T21:10:48.000Z","date":"2019-12-05","kind":"other","acquired":false,"shares":2551020,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By: Barer & Son Capital LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Pro rata distribution from Barer & Son Capital LLC, of which the Reporting Person is a member."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001192482-19-000509","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000119248219000509/edgar.xml","form_type":"4"}},{"id":3348344,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-09T21:10:48.000Z","date":"2019-12-05","kind":"gift","acquired":true,"shares":365854,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares gifted to the Reporting Person by the Sol J. Barer 2013 Grantor Retained Annuity Trust No. IV."}],"balance_after":1547732,"source":{"system":"sec-edgar","filing":"0001192482-19-000509","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000119248219000509/edgar.xml","form_type":"4"}},{"id":3348343,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-09T21:10:48.000Z","date":"2019-12-05","kind":"gift","acquired":false,"shares":365854,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By: Grantor Retained Annuity Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares gifted to the Reporting Person by the Sol J. Barer 2013 Grantor Retained Annuity Trust No. IV."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001192482-19-000509","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000119248219000509/edgar.xml","form_type":"4"}},{"id":3348342,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-09T21:10:48.000Z","date":"2019-12-05","kind":"gift","acquired":true,"shares":153846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Shares gifted to the Reporting Person by the wife of the Reporting Person."}],"balance_after":1181878,"source":{"system":"sec-edgar","filing":"0001192482-19-000509","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000119248219000509/edgar.xml","form_type":"4"}},{"id":3348341,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-09T21:10:48.000Z","date":"2019-12-05","kind":"gift","acquired":false,"shares":153846,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By: Wife"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares gifted to the Reporting Person by the wife of the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001192482-19-000509","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000119248219000509/edgar.xml","form_type":"4"}},{"id":3491984,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2019-06-13T10:02:28.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":31388,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on June 11, 2019 and vest on June 11, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on June 11, 2019 and vest on June 11, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":31388,"derivative":{"underlying":"Ordinary Shares","underlying_shares":31388},"source":{"system":"sec-edgar","filing":"0001209191-19-036582","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119036582/doc4.xml","form_type":"4"}},{"id":3501331,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-06-05T11:02:14.000Z","date":"2019-06-04","kind":"purchase","acquired":true,"shares":104500,"price":9.602,"value":1003409.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.57 to $9.63, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":220442,"source":{"system":"sec-edgar","filing":"0001209191-19-034611","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119034611/doc4.xml","form_type":"4"}},{"id":3505672,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-06-03T15:21:07.000Z","date":"2019-06-03","kind":"purchase","acquired":true,"shares":111000,"price":8.9821,"value":997013.1,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.915 to $9.095, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":115942,"source":{"system":"sec-edgar","filing":"0001209191-19-033779","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119033779/doc4.xml","form_type":"4"}},{"id":3519499,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2019-05-20T10:56:14.000Z","date":"2019-05-16","kind":"exercise","acquired":false,"shares":2780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on May 16, 2016 and vested on May 16, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on May 16, 2016 and vested on May 16, 2019."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2780},"source":{"system":"sec-edgar","filing":"0001209191-19-031203","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119031203/doc4.xml","form_type":"4"}},{"id":3519498,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-20T10:56:14.000Z","date":"2019-05-16","kind":"exercise","acquired":true,"shares":2780,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":4942,"source":{"system":"sec-edgar","filing":"0001209191-19-031203","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119031203/doc4.xml","form_type":"4"}},{"id":3590577,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2019-03-18T21:33:53.000Z","date":"2019-03-15","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Edge common stock upon the vesting of such unit."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of RSUs granted to the Reporting Person on August 14, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units shall become exercisable upon the achievement of certain performance or time based criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Expiration date is not applicable as the vested restricted stock units shall be settled on the first business day following the date that such restricted stock units vest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001127602-19-011903","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000112760219011903/form4.xml","form_type":"4"}},{"id":3590576,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-03-18T21:33:53.000Z","date":"2019-03-15","kind":"exercise","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of RSUs granted to the Reporting Person on August 14, 2018."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Meryl Barer, the wife of the Reporting Person.  The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Meryl Barer, the wife of the Reporting Person.  The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":678075,"source":{"system":"sec-edgar","filing":"0001127602-19-011903","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000112760219011903/form4.xml","form_type":"4"}},{"id":3826331,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2018-09-05T20:05:14.000Z","date":"2018-09-03","kind":"exercise","acquired":false,"shares":2162,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on October 7, 2015 and vested on September 3, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on October 7, 2015 and vested on September 3, 2018."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2162},"source":{"system":"sec-edgar","filing":"0001209191-18-049510","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118049510/doc4.xml","form_type":"4"}},{"id":3826330,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-09-05T20:05:14.000Z","date":"2018-09-03","kind":"exercise","acquired":true,"shares":2162,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":2162,"source":{"system":"sec-edgar","filing":"0001209191-18-049510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118049510/doc4.xml","form_type":"4"}},{"id":3840412,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-17T16:07:06.000Z","date":"2018-08-15","kind":"purchase","acquired":true,"shares":2551020,"price":0.96,"value":2448979.2,"ownership":{"direct":false,"nature":"By: Barer & Son Capital LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is a member of Barer & Son Capital LLC. As a member he has an economic interest in the assets owned by Barer & Son Capital LLC; however he has no control of the investment or disposition of such assets. Nevertheless, the reported shares may be deemed beneficially owned by the Reporting Person. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":2551020,"source":{"system":"sec-edgar","filing":"0001192482-18-000404","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000119248218000404/edgar.xml","form_type":"4"}},{"id":3843281,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2018-08-15T11:51:10.000Z","date":"2018-08-14","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Edge common stock upon the vesting of such unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units shall become exercisable upon the achievement of certain performance or time based criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Expiration date is not applicable as the vested restricted stock units shall be settled on the first business day following the date that such restricted stock units vest."}],"balance_after":20000,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001127602-18-025362","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000112760218025362/form4.xml","form_type":"4"}},{"id":3865487,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2018-07-18T16:23:38.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option award was granted on April 17, 2018 and was subject to forfeiture if stockholder approval of a proposed amendment to the Issuer's stock incentive plan to increase the number of shares reserved for issuance under the plan was not obtained. The Issuer's stockholders approved the amendment to the Issuer's stock incentive plan at the Issuer's annual meeting of stockholders on June 14, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This amendment is being filed to amend the vesting schedule of the option award. The entire option vests and becomes exercisable on April 17, 2019, subject to the reporting person's continued service with the Issuer."}],"balance_after":100000,"derivative":{"exercise_price":1.55,"expiration_date":"2028-04-17","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001192482-18-000346","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000119248218000346/edgar.xml","form_type":"4/A","original_submission_date":"2018-06-18"}},{"id":3887137,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true}}],"security":"Stock Option (Right To Purchase)","published_at":"2018-06-20T20:37:27.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options shall become exercisable upon the achievement of certain performance or time based criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These options expire on the third anniversary of the vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.1,"underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001127602-18-021592","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000112760218021592/form4.xml","form_type":"4"}},{"id":3890953,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2018-06-18T16:20:07.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option award was granted on April 17, 2018 and was subject to forfeiture if stockholder approval of a proposed amendment to the Issuer's stock incentive plan to increase the number of shares reserved for issuance under the plan was not obtained. The Issuer's stockholders approved the amendment to the Issuer's stock incentive plan at the Issuer's annual meeting of stockholders on June 14, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option award vests and becomes exercisable as follows (rounded up to the nearest whole share of common stock): one-third on April 17, 2019, then in 24 equal monthly installments on the 17th day of each subsequent calendar month, subject to the reporting person's continued service with the issuer."}],"balance_after":100000,"derivative":{"exercise_price":1.55,"expiration_date":"2028-04-17","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001192482-18-000300","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000119248218000300/edgar.xml","form_type":"4"}},{"id":3902682,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2018-06-07T10:52:11.000Z","date":"2018-06-05","kind":"grant","acquired":true,"shares":17565,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on June 5, 2018 and vest on June 5, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on June 5, 2018 and vest on June 5, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":17565,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17565},"source":{"system":"sec-edgar","filing":"0001209191-18-036203","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118036203/doc4.xml","form_type":"4"}},{"id":4184106,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2017-10-18T16:15:30.000Z","date":"2017-10-17","kind":"purchase","acquired":true,"shares":74912,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":74912,"derivative":{"exercise_price":2.84,"exercise_date":"2017-10-17","expiration_date":"2022-10-17","underlying":"Common Stock","underlying_shares":74912},"source":{"system":"sec-edgar","filing":"0001144204-17-053025","document":"tv477161_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000114420417053025/tv477161_4.xml","form_type":"4"}},{"id":4184105,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-18T16:15:30.000Z","date":"2017-10-17","kind":"purchase","acquired":true,"shares":421032,"price":1.26,"value":530500.32,"ownership":{"direct":true},"balance_after":1028032,"source":{"system":"sec-edgar","filing":"0001144204-17-053025","document":"tv477161_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000114420417053025/tv477161_4.xml","form_type":"4"}}],"next_cursor":"2017-10-18T16:15:30.000000Z,4184105"}